AURINIA PHARMACEUTICALS INC's ticker is and the CUSIP is 05156V952. A total of 4 filers reported holding AURINIA PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,755,241 | -2.8% | 483,300 | +21.0% | 0.01% | +8.3% |
| Q2 2023 | $3,865,224 | +60.2% | 399,300 | +81.3% | 0.01% | +33.3% |
| Q1 2023 | $2,413,392 | +441.9% | 220,200 | +113.6% | 0.01% | +800.0% |
| Q4 2022 | $445,392 | -75.7% | 103,100 | -57.7% | 0.00% | -75.0% |
| Q3 2022 | $1,833,000 | +1.2% | 243,700 | +35.2% | 0.00% | +33.3% |
| Q2 2022 | $1,811,000 | -12.3% | 180,200 | +8.1% | 0.00% | +50.0% |
| Q1 2022 | $2,064,000 | -84.0% | 166,700 | -70.5% | 0.00% | -80.0% |
| Q4 2021 | $12,926,000 | +6.2% | 565,200 | +2.8% | 0.01% | -23.1% |
| Q3 2021 | $12,169,000 | +292.5% | 549,900 | +129.9% | 0.01% | +225.0% |
| Q2 2021 | $3,100,000 | +96.8% | 239,200 | +97.2% | 0.00% | +100.0% |
| Q1 2021 | $1,575,000 | +26.4% | 121,300 | +34.6% | 0.00% | 0.0% |
| Q4 2020 | $1,246,000 | -26.7% | 90,100 | -22.0% | 0.00% | -60.0% |
| Q3 2020 | $1,701,000 | -25.9% | 115,500 | -18.3% | 0.01% | -54.5% |
| Q2 2020 | $2,296,000 | -36.7% | 141,300 | -43.5% | 0.01% | -62.1% |
| Q1 2020 | $3,630,000 | -58.8% | 250,200 | -42.4% | 0.03% | -51.7% |
| Q4 2019 | $8,801,000 | +1132.6% | 434,400 | +224.9% | 0.06% | +900.0% |
| Q3 2019 | $714,000 | +354.8% | 133,700 | +461.8% | 0.01% | +500.0% |
| Q2 2019 | $157,000 | +96.2% | 23,800 | +93.5% | 0.00% | 0.0% |
| Q1 2019 | $80,000 | -73.1% | 12,300 | -71.7% | 0.00% | -66.7% |
| Q4 2018 | $297,000 | -64.9% | 43,500 | -65.9% | 0.00% | -57.1% |
| Q3 2018 | $846,000 | +19.7% | 127,400 | +1.5% | 0.01% | +16.7% |
| Q2 2018 | $707,000 | -36.8% | 125,500 | -41.8% | 0.01% | -45.5% |
| Q1 2018 | $1,119,000 | -23.9% | 215,600 | -33.6% | 0.01% | +10.0% |
| Q4 2017 | $1,470,000 | -5.9% | 324,500 | +30.2% | 0.01% | -28.6% |
| Q3 2017 | $1,562,000 | +5.9% | 249,200 | +3.5% | 0.01% | -6.7% |
| Q2 2017 | $1,475,000 | -22.7% | 240,700 | -7.4% | 0.02% | -31.8% |
| Q1 2017 | $1,907,000 | +8981.0% | 259,800 | +2498.0% | 0.02% | – |
| Q4 2016 | $21,000 | – | 10,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Maven Securities LTD | 25,000 | $2,324,000 | 0.07% |
| GROUP ONE TRADING, L.P. | 565,200 | $12,926,000 | 0.01% |
| SIMPLEX TRADING, LLC | 173,600 | $3,970,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| JPMORGAN CHASE & CO | 130,700 | $2,989,000 | 0.00% |